Abstract
Continued administration of potent virally induced mouse interferon (IFN type I) preparations to suckling mice resulted in an inhibition of the primary antibody response to sheep erythrocytes (14-day-old mice). When slightly older suckling mice were immunized (17 days old), a delay (about 2 days) in the kinetics of the response was observed, but the amplitude of the response was similar in both control and IFN-treated animals. In adult mice, potent IFN preparations did not inhibit the antibody response under a variety of experimental conditions (different doses of IFN, schedules of treatment, routes of injection, times of assay). Although IFN does inhibit the in vitro antibody response, we conclude that under most experimental conditions, injection of IFN type I is not immunosuppressive in adult mice. When administered after immunization, IFN clearly enhanced the primary antibody response. It is of interest that IFN, a product of viral infection, enhances in vivo those components of the immune system that have been implicated in the host response to viral infections (i.e. delayed-type hypersensitivity, natural killer cell and macrophage activity, expression of lymphocyte membrane molecules), and, as is shown here, the primary a...Continue Reading
References
Nov 1, 1976·CRC Critical Reviews in Biochemistry·H M Johnson, S Baron
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·I GresserE De Maeyer
May 1, 1978·Infection and Immunity·O StrannegårdH Persson
Apr 1, 1979·Cellular Immunology·A SenikH Wigzell
Mar 15, 1978·Cellular Immunology·H M Johnson
Oct 27, 1978·Biochimica Et Biophysica Acta·I Gresser, M G Tovey
Mar 1, 1977·European Journal of Immunology·G J FinlayJ Marbrook
Dec 1, 1977·Cellular Immunology·I Gresser
Feb 1, 1976·The Australian Journal of Experimental Biology and Medical Science·R J BoothJ Marbrook
Sep 30, 1976·Nature·I GresserF Pontillon
Apr 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·P LindahlM Tovey
Nov 1, 1976·European Journal of Immunology·R J BoothJ Marbrook
Nov 1, 1975·Cellular Immunology·H M JohnsonS Baron
Nov 6, 1975·Nature·I GresserI Chouroulinkov
Apr 1, 1976·Infection and Immunity·R M Donahoe, K Y Huang
May 1, 1974·Cellular Immunology·G J ThorbeckeJ Vilcek
Oct 1, 1973·Die Naturwissenschaften·D GerickeP Chandra
Dec 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·W Braun, H B Levy
Nov 9, 1973·Nature·T J ChesterT C Merigan
Feb 1, 1974·Journal of the National Cancer Institute·I GresserD Brouty-Boyé
Jul 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·M G ToveyI Gresser
Sep 4, 1965·Nature·A J Cunningham
Mar 13, 1980·Nature·E De Maeyer, J De Maeyer-Guignard
Citations
Jun 1, 1984·European Journal of Clinical Microbiology·P J GrobM Fernex
May 5, 2001·Immunity·A Le BonD F Tough
Jan 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Scott E HensleyHildegund C J Ertl
May 1, 1991·The Journal of Experimental Medicine·I GresserF Belardelli
Jan 7, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Eleonora AricòAnthony A Nash
Dec 1, 1988·Journal of Interferon Research·E A MannD M Murasko
Mar 1, 1995·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·F Belardelli
Apr 23, 2004·Leukemia & Lymphoma·David F Tough
Jan 1, 1985·International Journal of Health Services : Planning, Administration, Evaluation·I Susser
Apr 22, 1982·Nature·J KnopE Macher
Jun 4, 1984·Nature·C L SidmanH M Johnson
Jun 1, 1983·European Journal of Immunology·F Arenzana-Seisdedos, J L Virelizier
May 1, 1984·Journal of Surgical Oncology·M G Ikossi-O'Connor, K C Chadha
Jan 1, 1986·CRC Critical Reviews in Biochemistry·M Rubinstein, P Orchansky